GL1X · GenesisL1 explorer

MolNFT v1 · #190130 · protein

Cryo-EM structure of the L-054,264-bound human SSTR2-GI1 complex

7WIG: “Cryo-EM structure of the L-054,264-bound human SSTR2-GI1 complex”. Electron microscopy, 1 ligand (9FI). MolNFT v1 #190130 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7WIG
Type
protein
Length
1,139 residues
Chains
5
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P30874, P63096, P54311, P63212
Ligands
9FI

Structure

electron microscopy · 5 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
R—protein283—P30874
A—protein225—P63096
B—protein339—P54311
G—protein58—P63212
S—protein234——

Ligands and binding sites

  • 9FI · ~{N}-[(2~{R})-1-[[(1~{R},3~{S})-3-(aminomethyl) cyclohexyl]methylamino]-3-(1~{H}-indol-3-yl)-1-oxidanylidene-propan-2-yl]spiro[indene-1,4'-piperidine]-1'-carboxamide · ligand · chains R

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7WIG · Cryo-EM structure of the L-054,264-bound human SSTR2-Gi1 complex · the same entry in another collection · chain S against S, TM-score 1.00
  • P54311 · AlphaFold monomer V2.0 prediction for guanine nucleotide-binding protein G(I)/G(S)/G(T)… · a predicted model of the same protein · chain B against A, TM-score 0.99
  • P30874 · AlphaFold monomer V2.0 prediction for somatostatin receptor type 2 (P30874) · a predicted model of the same protein · chain R against A, TM-score 0.90
  • P63096 · AlphaFold monomer V2.0 prediction for guanine nucleotide-binding protein G(I) subunit… · a predicted model of the same protein · chain A against A, TM-score 0.83
  • P63212 · AlphaFold monomer V2.0 prediction for guanine nucleotide-binding protein G(I)/G(S)/G(O)… · a predicted model of the same protein · chain G against A, TM-score 0.66

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.